Two Sigma Advisers’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $2.84M | Sell |
|
|||||
|
2023
Q3 | $9.96M | Sell |
|
|||||
|
2023
Q2 | $12.7M | Sell |
|
|||||
|
2023
Q1 | $12.3M | Buy |
|
|||||
|
2022
Q4 | $2.53M | Buy |
|
|||||
|
2022
Q3 | $1.33M | Buy |
|
|||||
|
2022
Q2 | $435K | Buy |
|
|||||
|
2022
Q1 | $395K | Sell |
|
|||||
|
2021
Q4 | $633K | Sell |
|
|||||
|
2021
Q3 | $1.4M | Sell |
|
|||||
|
2021
Q2 | $3.7M | Sell |
|
|||||
|
2021
Q1 | $5.98M | Buy |
|
|||||
|
2020
Q4 | $6.98M | Buy |
|
|||||
|
2020
Q3 | $2.96M | Buy |
|
|||||
|
2020
Q2 | $1.3M | Buy |
|
|||||
|
2020
Q1 | $521K | Buy |
|
|||||
|
2019
Q4 | $238K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $286K | Sell |
|
|||||
|
2018
Q4 | $190K | Sell |
|
|||||
|
2018
Q3 | $423K | Sell |
|
|||||
|
2018
Q2 | $867K | Sell |
|
|||||
|
2018
Q1 | $963K | Buy |
|
|||||
|
2017
Q4 | $134K | Buy |
|
|||||
|
2017
Q3 | $111K | Buy |
|